1.
Association studies of genetic polymorphisms and complex disease
by Chowdhury, Tahseen A
The Lancet (British edition), 2000-04-08, Vol.355 (9211), p.1277-1278
2.
Understanding cardiovascular development
by Grace, A A
The Lancet (British edition), 1995-04-08, Vol.345 (8954), p.915
3.
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
by Voight, Benjamin F, PhD
The Lancet (British edition), 2012-08-11, Vol.380 (9841), p.572-580
4.
HDL and cardiovascular disease
by Rader, Daniel J, Prof
The Lancet (British edition), 2014, Vol.384 (9943), p.618-625
5.
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
by Sarwar, Nadeem
The Lancet (British edition), 2012, Vol.379 (9822), p.1205-1213
6.
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
by Holmes, Michael V
The Lancet (British edition), 2012, Vol.379 (9822), p.1214-1224
7.
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
by Sarwar, Nadeem
The Lancet (British edition), 2010, Vol.375 (9726), p.1634-1639
8.
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase...
by Greenberg, Barry, Prof
The Lancet (British edition), 2016-03-19, Vol.387 (10024), p.1178-1186
9.
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses
by Ripatti, Samuli, Dr
The Lancet (British edition), 2010, Vol.376 (9750), p.1393-1400
10.
Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome
by Charchar, Fadi J, PhD
The Lancet (British edition), 2012, Vol.379 (9819), p.915-922
11.
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
by Talmud, Philippa J, Prof
The Lancet (British edition), 2013, Vol.381 (9874), p.1293-1301
12.
Dilated cardiomyopathy
by Jefferies, John Lynn, MD
The Lancet (British edition), 2010, Vol.375 (9716), p.752-762
13.
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
by Collet, Jean-Philippe, MD
The Lancet (British edition), 2009, Vol.373 (9660), p.309-317
14.
LDL cholesterol: controversies and future therapeutic directions
by Ridker, Paul M, Dr Prof
The Lancet (British edition), 2014, Vol.384 (9943), p.607-617
15.
Autosomal dominant polycystic kidney disease
by Torres, Vicente E, MD
The Lancet (British edition), 2007, Vol.369 (9569), p.1287-1301
16.
Hypertrophic cardiomyopathy
by Maron, Barry J, MD
The Lancet (British edition), 2013, Vol.381 (9862), p.242-255
17.
Genome-wide mapping of human loci for essential hypertension
by Caulfield, Mark
The Lancet (British edition), 2003-06-21, Vol.361 (9375), p.2118-2123
18.
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
by Raal, Frederick J, Prof
The Lancet (British edition), 2015, Vol.385 (9965), p.331-340
19.
Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease
by Katsuya, T
The Lancet (British edition), 1995-06-24, Vol.345 (8965), p.1600-1603
20.
Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome
by Behr, E
The Lancet (British edition), 2003-11-01, Vol.362 (9394), p.1457-1459
Filter electronic articles 89 Hits
Remove Filters
- Journal Title
- The Lancet
- Lancet (3)
- Subjects
- Genetic Aspects
- Science & Technology (80)
- Life Sciences & Biomedicine (80)
- more ...